The points raised here about proactive versus reactive communication are well-taken, but I think there's an underlying issue worth naming more explicitly: communication plans fail not because they're ...

Partnering with a CRO doesn't eliminate risk so much as it redistributes it. You're trading execution risk for coordination risk; gaining the CRO's expertise and infrastructure while simultaneously in...

The points raised about timing and legal versus ethical disclosure really stand out to me as I think Dev's framing is spot on: meeting regulatory minimums is not the same as being ethical, and in medi...

Both points about false alignment and the danger of locked-in assumptions really resonate with me. During my time at Boston Scientific, working on a delivery system for a next-generation heart valve, ...

Building on the point about revisiting cost estimates as the project progresses, it's worth highlighting that in the medical device space specifically, PMs can leverage a risk-based contingency framew...

One dimension worth adding to this discussion is the role that supplier qualification and audit processes play in preventing this situation from arising in the first place. Ideally, before a contracte...

A technical lead telling upper management that a timeline is unrealistic will land very differently if they frame it in terms of regulatory risk, potential FDA audit failures, or product liability exp...

One angle that hasn't been fully explored is the idea of designating a lead PM who serves as the final decision-maker when conflicts arise, essentially functioning as a tiebreaker while still distribu...

There's a difference between a company that rushes a product to market while deliberately concealing known safety concerns versus one that makes a calculated, transparent decision to accelerate timeli...

Instead of only adding buffer time at the end, it can be more effective to distribute smaller buffers around high-risk or high-variability tasks, especially those on the critical path. Building on the...

One point that stands out to me from this discussion is how critical it is to treat the initiation phase as a stage for managing uncertainty rather than eliminating it. In fields like medical device d...

One strategy that stands out to me is the role of organizational procedures, because they create the structure that allows the other tools, like meetings or tracking systems, to work effectively. Whil...

One aspect of EVM I find particularly valuable is its ability to improve communication between project teams and stakeholders. While several posts mentioned tracking performance and forecasting outcom...

I agree with many of the points mentioned, especially about creativity and negotiation leverage, but another possible reason could be strategic flexibility for upper management. Sometimes the total bu...

I agree with many of the points about checklists and pre-review meetings, but another helpful step is making sure the story of the design is clear before the meeting. Instead of just compiling documen...